chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the patient used to get the flu shot and always got the flu; Initial information regarding this unsolicited valid non-serious social media case was received from a consumer on 17-Oct-2020.  This case was linked to cases 2020SA294179, 2020SA294180, 2020SA294181, 2020SA294182, 2020SA294183, 2020SA294184, 2020SA294185, 2020SA294186, 2020SA294187, 2020SA294133, 2020SA294189, 2020SA294190, 2020SA294191, 2020SA294192, 2020SA294193, 2020SA294194 and 2020SA294195.  This case involved a patient of unknown demographics who used to get the INFLUENZA VACCINE (flu shot) and always got the flu (influenza).  Relevant medical history, past medical treatment, vaccination details and concomitant medication family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, it was reported that the patient always developed a non-serious flu (influenza), unknown latency following the administration of INFLUENZA VACCINE. The patient reported that it was horrible every time the patient got it. People told the patient to imagine how bad it would had been if you had not gotten the flu shot. The patient finally quit getting the flu shot and now, rarely got the flu and if the patient did get it, it was mild. The patient would never again get a flu shot.  Relevant laboratory test was not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
Exactly one week after the second shot, on 2/16/2021,  I started getting very itchy on my wrists and noticed little bumps.  Then my ankles became itchy and the same little bumps occurred.   They continue to itch and I have gotten other areas that are becoming itchy and little bumps are appearing.  I awake at night feeling itchy.  My scalp is also itching.  I am on day four of itching as I write this.  The bumps remain.  I also get occasional flushing on my face under my eyes and across the bridge of my nose.  I have been taking lots of allergy meds as I have a fear it could cause breathing issues if I don?t.  It has helped a bit but does not last as long as I would like so I?m taking more pills than I prefer!
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 09-OCT-2012 12:56, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not provided. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0395AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Pt vaccinated with Engerix-B developed general malaise, adverse reaction to vaccination, body aches, chills.
had splitting headaches for 12 hours; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from a sales representative.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "had splitting headaches for 12 hours".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201185411 same reporter/drug, event, different patients;
Had PEA and has been hospitalized x3, having recurring vfib, no prior cardiac history and had clean cath
She had a tiny bit of soreness if she touched the vaccine injection site, but did not experience any soreness if she moved or lifted her arm; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 16Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she had her first dose of the Pfizer COVID-19 Vaccine on Saturday, 16Jan2021, with no side effects. The patient stated that she had read in the past that taking 1 ibuprofen before and after the flu vaccine was recommended. She said she also had medical people tell her the same. She recently read a study where it is recommended a person shouldn't take ibuprofen before or after receiving the COVID-19 Vaccine because the ibuprofen might interfere with the vaccine's effectiveness. She said she is now in a bit of a quandary moving forward, as to if she should take any kind of analgesic, or Ibuprofen, or anything of that nature before getting her second COVID-19 Vaccine dose. She took 1 Advil prior to receiving her first dose of the COVID-19 Vaccine. She wanted to know if she should not take any ibuprofen before her second COVID-19 Vaccine dose. The patient reported further that on 16Jan2021, she had a tiny bit of soreness in her arm, only if she touched the COVID-19 Vaccine injection site. She does not experience any soreness if she moved or lift her arm. Outcome of the event was unknown.  Information on the batch/lot number has been requested.
mom states pt exp episode of screaming x 3 hrs; pt was lethargic & weak; no fever; approx 2 hrs p/vax called MD 530-6PM & was told to watch pt & gave APAP; taken to ER;
felt like got  an  infection; small red welts rash/Rash like big round red welts all over; itched a lot; small rash/Rash like big round red welts all over; This spontaneous case was reported by a consumer and describes the occurrence of INFECTION (felt like got  an  infection), URTICARIA (small red welts rash/Rash like big round red welts all over), PRURITUS (itched a lot) and RASH (small rash/Rash like big round red welts all over) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027821A and 010A21A) for COVID-19 vaccination.     Concomitant products included VITAMIN D [VITAMIN D NOS], METFORMIN, AMLODIPINE, GLIMEPIRIDE, LOVASTATIN, SITAGLIPTIN PHOSPHATE (JANUVIA), METOPROLOL and INSULIN GLARGINE (LANTUS) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INFECTION (felt like got  an  infection), URTICARIA (small red welts rash/Rash like big round red welts all over), PRURITUS (itched a lot) and RASH (small rash/Rash like big round red welts all over). The patient was treated with HYDROCORTISONE (topical) for Rash and Itch, at an unspecified dose and frequency; CLOBETASOL (topical) for Itch and Rash, at an unspecified dose and frequency and TRIAMCINOLONE (topical) for Infection, Rash and Itch, at an unspecified dose and frequency. At the time of the report, INFECTION (felt like got  an  infection), URTICARIA (small red welts rash/Rash like big round red welts all over), PRURITUS (itched a lot) and RASH (small rash/Rash like big round red welts all over) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Muscle Relaxer, Blood pressure medications, Gout medication, Pain medication, Stomach medication, Cholesterol medication.  Treatment medications oral steroid to treat the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up document contained information such as patient details, concomitant and treatment medications, additional events which were updated.
Persisten high pitch ringing in my ears, started about an hour or so after my second shot.  I had no symptoms after shot 1, 2nd shot I felt a bit foggy within the first 30 mins, this lasted maybe a day but I was still able to function normally.  The ringing in my ears I noticed when I was close to home on the commute back from the hostpital, probably around 90 mins after the shot.  It has not got better, in fact, just recently it has got louder and its starting to become much more noticeable to me.
Still pink; Slightly Itchy; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOSENSITIVITY REACTION (Still pink) and PRURITUS (Slightly Itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PHOTOSENSITIVITY REACTION (Still pink) and PRURITUS (Slightly Itchy). At the time of the report, PHOTOSENSITIVITY REACTION (Still pink) and PRURITUS (Slightly Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
High fever (101 degrees F), sweats, chills, aching all over. ADVIL 600 g every 6 hours, helps but not to normal temp.
Narrative: This is a report to suggest/investigate if this PE could be COVID vaccine related vs apixaban failure related. In both cases it is a question we have and reporting is to inform of the possibility, especially in light of recent (different brand) COVID vaccine related clotting
Local vaccine reaction: Right thigh: 30x18mm area of redness and swelling.
redness, soreness, swelling & lump, hot to touch, hurting;abscess @ site, drained blood & blood clots w/some purulence;placed on ATB & sterile dressing applies;
I tested positive and felt fine.  I had a sore throat and a stuffy nose and a cough.  It felt like a bad cold.  The following evening, I had a fever which lasted 12 hours.  I also felt tired.  Mostly the symptoms were sore throat and tired.  My husband had COVID as well, he took Paxlovid and had a rebound.  I did not take any medication other than Tylenol for the fever.  I think we both might have COVID again.  We both have pink eye as well.  One week I test positive, and I felt fine, but then I have pink eye.  I do still have a little cough but that is it.
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 7/14/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY I63.81 ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 8/18/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 6/4/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY J96.00 ACUTE RESPIRATORY FAILURE 6/16/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY R09.02 HYPOXIA 6/4/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
little bit of body aches; low grade temperature; it was just an off day; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (little bit of body aches), PYREXIA (low grade temperature) and FEELING ABNORMAL (it was just an off day) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included MS.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced PAIN (little bit of body aches), PYREXIA (low grade temperature) and FEELING ABNORMAL (it was just an off day). At the time of the report, PAIN (little bit of body aches), PYREXIA (low grade temperature) and FEELING ABNORMAL (it was just an off day) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient went off her immunosuppressant medication when Covid-19 first hit.  No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2021-408541, MOD-2021-408555 (Patient Link).
This spontaneous report was received from a physician regarding a 5 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions and concomitant medications were not reported. On 09-SEP-2016, the patient was vaccinated with VAQTA (reported as Hep A) lot# M015290 with expiration date 20-SEP-2017 (dose, route and frequency were not reported) and RECOMBIVAX HB (reported as Hep A) lot# L045117 with expiration date 10-JUN-2018 (dose, route and frequency were not reported) for prophylaxis when refrigerator was out of range (Incorrect product storage). This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA004566: US-009507513-1701USA004717: US-009507513-1701USA004718: US-009507513-1701USA004719: US-009507513-1701USA004721: US-009507513-1701USA004722: US-009507513-1701USA004723: US-009507513-1701USA004724: US-009507513-1701USA004725: US-009507513-1701USA004726.
Heart beat increased; This spontaneous case was reported by a patient and describes the occurrence of HEART RATE INCREASED (Heart beat increased) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced HEART RATE INCREASED (Heart beat increased). At the time of the report, HEART RATE INCREASED (Heart beat increased) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment or concomitant medications reported.
Immediate reaction - "not feeling well", dizzy to the point that he was not safe to walk Blood pressure had been a little above normal prior to vaccination and remained high during the half hour of observation, but had started to come down a few points by the time he was taken in a wheelchair to family to go home and rest.
This case was reported by a healthcare professional and described the occurrence of swelling injection site in a 5-year-old male subject who was vaccinated with INFANRIX (GlaxoSmithKline). Concurrent medical conditions included allergies and eczema. Concurrent vaccinations given on 20 August 2008 included the 1st dose of FLUMIST MedImmune; intranasal; and IPOL; Sanofi Pasteur; unknown. On 20 August 2008, the subject received the 5th dose of INFANRIX (.5 ml, unknown, left arm). At an unspecified time after vaccination with INFANRIX, the subject experienced swelling at the injection site and injection site redness. The reporter indicated that medical attention was required at the physician's office. The reporter stated that the INFANRIX vaccination series was neither discontinued, nor delayed. At the time of reporting, the outcome of the events was unspecified. Follow-up information was received on 12 September 2008 via a nurse, who reported that the onset of the events occurred on 22 August 2008, two days after vaccination with INFANRIX. After an unspecified period of time, the events were resolved. The healthcare professional considered the events to be related to vaccination with INFANRIX, but indicated that she did not consider the events to be serious. The healthcare professional also indicated that the INFANRIX vaccination series was neither discontinued, nor delayed.
Her husband in particular has had a few inflammatory responses; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed; but unknown manufacturer), for Covid-19 Immunization. The following information was reported: INFLAMMATION (non-serious), outcome "unknown", described as "Her husband in particular has had a few inflammatory responses". Additional information: Reporter stated that the people that she knew are clearly nervous getting the bivalent, given what she had experienced, but everyone responded differently. Her husband (patient) in particular has had a few inflammatory responses, not anywhere like this but a hip flare or something.Caller stated that she's wondering if inflammation is reported after the vaccine. Its a big question for her family. Both her and her husband (patient) had both experienced it. She had a tear in her hip that she had surgically repaired and one of vaccines, one of the times she got a booster set off a flare in her hip. Her husband (patient) had the same experience with his knees. She was just wondering if it was anecdotal or if that's something there is data on. Knock on wood, neither of her or her husband have had Covid. It made to wonder if the side effects are worse than the disease but they really don't want to get it, especially with long Covid.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Pt complaining of nausea and vomited. Then complained of severe headache and the lightheadedness. No redness or swelling at injection site. BP 118/76 in left arm, Radial Pulse 76, Respirations 24. Face flushed. Skin warm. Parent called and instructed to observe. Call to pt on 2/17/2000 at 14:00, headache less severe and no further nausea and vomiting. On 2/18/2000 went to school today. Arm is sore but feeling alright otherwise. Headache resolved.
I spoke to my sister on the phone an hour or two after she got the vaccine and she was slurring her words.  The next day around 5:38 someone called me to say she was found on the floor in the bathroom between the toilet and the wall.  I believe she passed out because she has no recollection of what happened at that time.   She was also reported as having a very dry mouth and sweating by the staff.   She was taken to  ER after they found her in the bathroom. She is currently having trouble getting around, has pain and is very tired.  She seems to be improving though.
A report has been received from a Health Professional concerning a 12 year old, Male subject, who had been receiving nasal FLUMIST. FLUMIST started on 16-Sep-2012. The patient experienced TESTED POSITIVE FLU A which started on 12-Dec-2012 and EAR INFECTION. The patient recovered from the event of TESTED POSITIVE FLU A and EAR INFECTION on an unspecified date. The report was considered to be non-serious. Summary of follow-up information received 26-Feb-2013 from Health professional. Non serious event of ear infection was added. Outcome for the events of tested positive Flu A and ear infection was updated as recovered. lot number and expiry date added for FLUMIST.
This case was reported by a pharmacist via call center representative and described the occurrence of swelling in a 49-year-old female patient who received SHINGRIX (batch number 77PL3, expiry date 18th April 2021) for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On 10th November 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) 50 µg. On an unknown date, the patient received the 1st dose of SHINGRIX. On 10th November 2018, unknown after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced inappropriate age at vaccine administration. On 12th November 2018, the patient experienced swelling, skin blotches and skin discoloration. On 13th November 2018, the patient experienced pruritus. On an unknown date, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the swelling, skin blotches, skin discoloration and pruritus were not recovered/not resolved and the outcome of the inappropriate age at vaccine administration and inappropriate age at vaccine administration were unknown. It was unknown if the reporter considered the swelling, skin blotches, skin discoloration and pruritus to be related to SHINGRIX. Additional information received as follows: The patient received SHINGRIX in the left deltoid. The patient developed 2 large blotches on her right arm those were swollen and had some white dots on them and they itched. The patient received 1st dose and 2nd dose of SHINGRIX at the age of 49 years, which led to inappropriate age at vaccine administration. The reporter gave consent to follow up. Unable to confirm if the patient's date of birth was correctly reported.
Information has been received from a certified medical assistant referring to a male patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. On an unknown date the patient was vaccinated with GARDASIL 1 dose (dose, route, lot# and expiration date were not reported) for the first dose in the human papillomavirus vaccine (HPV) series and then was administered GARDASIL 9 (dose, route, lot# and expiration date were not reported) for the second and third doses in the HPV series (interchange of vaccine products). This was outside the labeled recommendations in both the GARDASIL and GARDASIL 9 prescribing information (off label use). No adverse effect was reported. Outcome of the events and the causality were not reported. Additional information has been requested.
She had more energy; This is a spontaneous report received from a contactable consumer. This report is a response to mail trail sent regarding the confirmation of query: Pfizer COVID vaccine can do more than being seen. A 91-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The reporter reported that the patient (mom of reporter) had problems getting going in the morning but when she had her second Pfizer COVID shot she felt great. She had more energy, she felt younger and was more active for about 6 weeks. Then she lost that energy, and she was back to feeling 91 again. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.